Cross-talks between osteoporosis and gut microbiome.

Area of Science:

• Microbiology
• Immunology
• Bone Biology

Background:

• The gut microbiome, a complex microbial community in the human gut, is vital for physiological functions.
• Gut dysbiosis, an imbalance in the gut microbiota, is implicated in the pathogenesis of diseases like osteoporosis.
• Osteoporosis is a skeletal disease marked by low bone mass and increased fracture risk.

Purpose of the Study:

• To explore the role of gut microbes in osteoporosis development and progression.
• To investigate the mechanisms by which gut microbiota influences bone metabolism.
• To assess the potential of gut microbiome modulation as a therapeutic strategy for osteoporosis.

Main Methods:

• Review of molecular biology advances and research on gut microbiota and osteoporosis.
• Analysis of mechanisms including immunoregulation, gut-brain axis, intestinal barrier function, and nutrient absorption.
• Examination of microbial effects on osteoclast and osteoblast activity.

Main Results:

• Gut microbiota can influence bone mass by modulating immune responses and metabolic pathways.
• Specific microbial actions include inhibiting osteoclast differentiation, reducing bone resorption, and promoting osteoblast activity.
• Gut microbiota impacts bone health via the gut-brain axis and regulation of nutrient absorption.

Conclusions:

• Gut microbiota plays a significant role in osteoporosis pathogenesis and progression.
• Targeting the gut microbiome offers potential for early diagnosis, intervention, and adjunct therapy for osteoporosis.
• Further research is crucial to fully understand and utilize the therapeutic potential of microbiome modulation for bone health.